Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT02526797 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Multiparametric MRI in Men With Prostate Cancer Undergoing Active Surveillance

StatusEnrolling by Invitation
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 1 year 4 months later Jul 2026 → Dec 2027
See other at-risk trials from Herlev Hospital

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary completion pushed from Jul 2026 to Dec 2027
    • Study completion pushed from Dec 2026 to Dec 2027
    • Eligibility criteria expanded, about 12 words
  2. Primary completion date: Jul 2023 to Jul 2026
    • Study completion date: Dec 2023 to Dec 2026
    v8
  3. Re-verified, no change to tracked fieldsv7
  4. Primary completion date: Jul 2021 to Jul 2023
    • Study completion date: Dec 2021 to Dec 2023
    v6
  5. Primary completion date: Jul 2020 to Jul 2021
    • Study completion date: Dec 2020 to Dec 2021
    v5
Show 3 earlier versionsHide 3 earlier versions
  1. Primary completion date: Jun 2019 to Jul 2020v4
  2. Primary completion date: Jun 2015 to Jun 2019
    • Study completion date: Dec 2017 to Dec 2020
    v3
  3. Study completion date: Dec 2015 to Dec 2017v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Herlev Hospital
27 trials monitored
See 3 trials at risk
Prostate Cancer
2,546 trials monitored
See 172 trials at risk
To investigate whether multiparametric MRI (mp-MRI) in patients with low-risk prostate cancer can improve the selection of patients suitable for Active Surveillance and have a relevance in the ongoing monitoring.
Trial Details
NCT Number NCT02526797
Lead Sponsor Herlev Hospital
Conditions
(from sponsor)		 Prostatic Neoplasms
Related terms Prostatic Neoplasms
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov